Company Profile

Theron Pharmaceuticals Inc
Profile last edited on: 1/11/2018      CAGE: 5BD91      UEI: H9MKFLCUJK31

Business Identifier: Therapeutic products for the treatment of chronic respiratory diseases
Year Founded
2008
First Award
2010
Latest Award
2016
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

365 San Aleso Avenue
Sunnyvale, CA 94085
   (408) 792-7424
   info@theronpharma.com
   www.theronpharma.com
Location: Single
Congr. District: 17
County: Santa Clara

Public Profile

Theron Pharmaceuticals is a privately held biotechnology company with it earlier roots in the Panorama Research incubation systems. Theron is developing a long acting M3 muscarinic antagonist (LAMA) for the improved treatment of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD) and severe asthma. The goal of Theron's LAMA program is to develop a once-daily inhaled bronchodilator that possesses the adequate physicochemical properties for broad inhalation device flexibility (DPI, MDI and nebulizer) in addition to excellent co-formulation compatibility for use in multi-drug combination products.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
10-14

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2016 2 NIH $1,569,916
Project Title: Pharmacological Characterization of a Novel Rock Inhibitor for COPD

Key People / Management

  Xiaoming Zhang -- Co-Founder

  Jürg Pfister -- Founder

  M (Venkat) Venkatraman -- Co-Founder

Company News

There are no news available.